Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001386795.1(DTNA):c.15T>A(p.Ser5Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
DTNA (HGNC:3057): (dystrobrevin alpha) The protein encoded by this gene belongs to the dystrobrevin subfamily of the dystrophin family. This protein is a component of the dystrophin-associated protein complex (DPC), which consists of dystrophin and several integral and peripheral membrane proteins, including dystroglycans, sarcoglycans, syntrophins and alpha- and beta-dystrobrevin. The DPC localizes to the sarcolemma and its disruption is associated with various forms of muscular dystrophy. Mutations in this gene are associated with left ventricular noncompaction with congenital heart defects. Multiple alternatively spliced transcript variants encoding different isoforms have been identified for this gene. [provided by RefSeq, Jul 2008]
Uncertain significance, criteria provided, single submitter
clinical testing
Labcorp Genetics (formerly Invitae), Labcorp
Jun 15, 2022
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. This variant has not been reported in the literature in individuals affected with DTNA-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces serine, which is neutral and polar, with arginine, which is basic and polar, at codon 5 of the DTNA protein (p.Ser5Arg). -
Loss of phosphorylation at K5 (P = 0.0121);Loss of phosphorylation at K5 (P = 0.0121);Loss of phosphorylation at K5 (P = 0.0121);Loss of phosphorylation at K5 (P = 0.0121);Loss of phosphorylation at K5 (P = 0.0121);Loss of phosphorylation at K5 (P = 0.0121);Loss of phosphorylation at K5 (P = 0.0121);Loss of phosphorylation at K5 (P = 0.0121);Loss of phosphorylation at K5 (P = 0.0121);Loss of phosphorylation at K5 (P = 0.0121);Loss of phosphorylation at K5 (P = 0.0121);Loss of phosphorylation at K5 (P = 0.0121);Loss of phosphorylation at K5 (P = 0.0121);Loss of phosphorylation at K5 (P = 0.0121);Loss of phosphorylation at K5 (P = 0.0121);Loss of phosphorylation at K5 (P = 0.0121);Loss of phosphorylation at K5 (P = 0.0121);